During the last session, Aileron Therapeutics Inc (NASDAQ:ALRN)’s traded shares were 0.35 million, with the beta value of the company hitting 2.33. At the end of the trading day, the stock’s price was $3.73, reflecting an intraday gain of 28.18% or $0.82. The 52-week high for the ALRN share is $7.42, that puts it down -98.93 from that peak though still a striking 72.92% gain since the share price plummeted to a 52-week low of $1.01. The company’s market capitalization is $80.83M, and the average intraday trading volume over the past 10 days was 0.12 million shares, and the average trade volume was 78.04K shares over the past three months.
Aileron Therapeutics Inc (NASDAQ:ALRN) trade information
Aileron Therapeutics Inc (ALRN) registered a 28.18% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 28.18% in intraday trading to $3.73, hitting a weekly high. The stock’s 5-day price performance is 36.13%, and it has moved by 45.70% in 30 days. Based on these gigs, the overall price performance for the year is 137.58%. The short interest in Aileron Therapeutics Inc (NASDAQ:ALRN) is 0.3 million shares and it means that shorts have 6.16 day(s) to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Aileron Therapeutics Inc (ALRN) estimates and forecasts
Statistics show that Aileron Therapeutics Inc has outperformed its competitors in share price, compared to the industry in which it operates. Aileron Therapeutics Inc (ALRN) shares have gone down -34.22% during the last six months, with a year-to-date growth rate more than the industry average at 55.94% against 17.30. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 61.00% this quarter and then jump 71.40% in the quarter after that.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 39.67%. While earnings are projected to return 58.75% in 2024, the next five years will return 2.10% per annum.
ALRN Dividends
Aileron Therapeutics Inc is due to release its next quarterly earnings on 2024-Oct-11. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Aileron Therapeutics Inc (NASDAQ:ALRN)’s Major holders
Aileron Therapeutics Inc insiders own 0.65% of total outstanding shares while institutional holders control 31.86%, with the float percentage being 32.07%. HEXAGON CAPITAL PARTNERS LLC is the largest shareholder of the company, while 32.0 institutions own stock in it. As of 2024-06-30, the company held over 213.0 shares (or 0.0026% of all shares), a total value of $591.0 in shares.
